TRCT
TGX

Tower Research Capital (TRC)’s THERAGENICS CORP TGX Stock Holding History

Tower Research Capital (TRC)’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-900
Closed -$2K – 5439
2013
Q3 		$2K Sell
900
-4,500
-83% -$9.59K ﹤0.01% 4234
2013
Q2 		$11K Buy
+5,400
New +$9.66K ﹤0.01% 2343

Tower Research Capital (TRC)'s TGX Position: Q4 2013 in Review

Tower Research Capital (TRC) sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 900 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $11K in Q2 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Tower Research Capital (TRC) reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 900 THERAGENICS CORP shares in Q4 2013, an estimated $2K.
  • Tower Research Capital (TRC) first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s THERAGENICS CORP position peaked at $11K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2013, filed 31 Jan 2014.